<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0075">
 <element-citation publication-type="journal" id="sbref0075">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Jin</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</article-title>
  <source>Lancet</source>
  <issue>April</issue>
  <year>2020</year>
  <comment>Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/abstract. [Cited 12 May 2020]</comment>
 </element-citation>
</ref>
